Novel nano-rough polymers for cartilage tissue engineering

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 1845-1853

  Balasundaram, Ganesan ^a   Storey, Daniel M ^a   Webster, Thomas J ^b,c  

^a Surfatek   (United States)

^b Northeastern University   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cartilage applications; Chondrocytes; Nano roughened polymers; Polycaprolactone; Polyurethane

Indexed keywords

POLYCAPROLACTONE; POLYURETHAN; TISSUE SCAFFOLD; TITANIUM; BIOMATERIAL; NANOPARTICLE; POLYESTER;

ARTICLE; ATOMIC FORCE MICROSCOPY; CARTILAGE; CARTILAGE CELL; CELL COUNT; COLLAGEN SYNTHESIS; CONTACT ANGLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOANALYSIS; NANOFABRICATION; PHYSICAL CHEMISTRY; POROSITY; PROTEIN SYNTHESIS; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE ENGINEERING; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; CRYSTALLIZATION; CYTOLOGY; DEVICES; GROWTH, DEVELOPMENT AND AGING; MATERIALS TESTING; PARTICLE SIZE; PHYSIOLOGY; PROCEDURES; SYNTHESIS; TISSUE SCAFFOLD; ULTRASTRUCTURE;

BIOCOMPATIBLE MATERIALS; CARTILAGE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; CRYSTALLIZATION; HUMANS; MATERIALS TESTING; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYURETHANES; SURFACE PROPERTIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84898640767     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S55865     Document Type: Article

References (33)

1. Brooks PM. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002; 14(5): 573-577.
2. Lawrence RC, Felson DT, Helmick CG, et al; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008; 58(1): 26-35.
3. Dillon CF, Rasch EK, Gu Q, Hirsch R. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J Rheumatol. 2006; 33(11): 2271-2279.
4. Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C; Community Hypertension and Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis. 2004; 63(4): 395-401.
5. Niu J, Zhang YQ, Torner J, et al. Is obesity a risk factor for progressive radiographic knee osteoarthritis? Arthritis Rheum. 2009; 61(3): 329-335.
6. Sun BH, Wu CW, Kalunian KC. New developments in osteoarthritis. Rheum Dis Clin North Am. 2007; 33(1): 135-148.
7. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol. 2006; 18(1): 64-73.
8. Stoddart MJ, Grad S, Eglin D, Alini M. Cells and biomaterials in cartilage tissue engineering. Regen Med. 2009; 4(1): 81-98.
9. Kaufman MR, Tobias GW. Engineering cartilage growth and development. Clin Plast Surg. 2003; 30(4): 539-546.
10. Almarza AJ, Athanasiou KA. Design characteristics for the tissue engineering of cartilaginous tissues. Ann Biomed Eng. 2004; 32(1): 2-17.
11. Redman SN, Oldfield SF, Archer CW. Current strategies for articular cartilage repair. Eur Cell Mater. 2005; 9: 23-32; discussion 23-32.
12. Chung C, Burdick JA. Engineering cartilage tissue. Adv Drug Deliv Rev. 2008; 60(2): 243-262.
13. Becerra J, Andrades JA, Guerado E, Zamora-Navas P, López-Puertas JM, Reddi AH. Articular cartilage: structure and regeneration. Tissue Eng Part B Rev. 2010; 16(6): 617-627.
14. Gloria A, De Santis R, Ambrosio L. Polymer-based composite scaffolds for tissue engineering. J Appl Biomater Biomech. 2010; 8(2): 57-67.
15. Lu L, Zhu X, Valenzuela RG, Currier BL, Yaszemski MJ. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop Relat Res. 2001; (Suppl 391): S251-S270.
16. Sohier J, Moroni L, van Blitterswijk C, de Groot K, Bezemer JM. Critical factors in the design of growth factor releasing scaffolds for cartilage tissue engineering. Expert Opin Drug Deliv. 2008; 5(5): 543-566.
17. de Groot JH. Polyurethane scaffolds for meniscal tissue regeneration. Med Device Technol. 2005; 16(7): 18-20.
18. Chia SL, Gorna K, Gogolewski S, Alini M. Biodegradable elastomeric polyurethane membranes as chondrocyte carriers for cartilage repair. Tissue Eng. 2006; 12(7): 1945-1953.
19. Tsui YK, Gogolewski S. Microporous biodegradable polyurethane membranes for tissue engineering. J Mater Sci Mater Med. 2009; 20(8): 1729-1741.
20. Alves da Silva ML, Martins A, Costa-Pinto AR, et al. Cartilage tissue engineering using electrospun PCL nanofiber meshes and MSCs. Biomacromolecules. 2010; 11(12): 3228-3236.
21. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(epsilon-caprolactone) scaffolds. J Biomed Mater Res A. 2003; 67(4): 1105-1114.
22. Eyrich D, Wiese H, Maier G, et al. In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Eng. 2007; 13(9): 2207-2218.
23. Izquierdo R, Garcia-Giralt N, Rodriguez MT, et al. Biodegradable PCL scaffolds with an interconnected spherical pore network for tissue engineering. J Biomed Mater Res A. 2008; 85(1): 25-35.
24. Chang KY, Hung LH, Chu IM, Ko CS, Lee YD. The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering. J Biomed Mater Res A. 2010; 92(2): 712-723.
25. Khang D, Carpenter J, Chun YW, Pareta R, Webster TJ. Nanotechnology for regenerative medicine. Biomed Microdevices. 2010; 12(4): 575-587.
26. Park GE, Pattison MA, Park K, Webster TJ. Accelerated chondrocyte functions on NaOH-treated PLGA scaffolds. Biomaterials. 2005; 26(16): 3075-3082.
27. Savaiano JK, Webster TJ. Altered responses of chondrocytes to nanophase PLGA/nanophase titania composites. Biomaterials. 2004; 25(7-8): 1205-1213.
28. Kay S, Thapa A, Haberstroh KM, Webster TJ. Nanostructured polymer/nanophase ceramic composites enhance osteoblast and chondrocyte adhesion. Tissue Eng. 2002; 8(5): 753-761.
29. Dalby MJ, Childs S, Riehle MO, Johnstone HJ, Affrossman S, Curtis AS. Fibroblast reaction to island topography: changes in cytoskeleton and morphology with time. Biomaterials. 2003; 24(6): 927-935.
30. Miller DC, Haberstroh KM, Webster TJ. Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. J Biomed Mater Res A. 2005; 73(4): 476-484.
31. Thapa A, Miller DC, Webster TJ, Haberstroh KM. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials. 2003; 24(17): 2915-2926.
32. Thapa A, Webster TJ, Haberstroh KM. Polymers with nano-dimensional surface features enhance bladder smooth muscle cell adhesion. J Biomed Mater Res A. 2003; 67(4): 1374-1383.
33. Miller DC, Haberstroh KM, Webster TJ. PLGA nanometer surface features manipulate fibronectin interactions for improved vascular cell adhesion. J Biomed Mater Res A. 2007; 81(3): 678-684.